Crohn's Disease

Crohn’s disease is a chronic inflammatory disease of the bowel affecting at least 115,000 people in the UK. The condition usually develops in teenagers and young adults, but can be diagnosed at any age and is equally common in men and women.

Overview

Feature Articles

Latest Crohn's Disease News and Research

Sulfide-producing bacteria may explain lingering symptoms in Crohn's disease

Sulfide-producing bacteria may explain lingering symptoms in Crohn's disease

NYU Langone IBD Center celebrates two years of transforming lives

NYU Langone IBD Center celebrates two years of transforming lives

Filgotinib offers new promise for managing Crohn’s disease

Filgotinib offers new promise for managing Crohn’s disease

Specific protein patterns can predict IBD up to 16 years before diagnosis

Specific protein patterns can predict IBD up to 16 years before diagnosis

More than 100,000 young people in the US live with inflammatory bowel disease

More than 100,000 young people in the US live with inflammatory bowel disease

New molecule promotes gut healing and suppresses tumor growth in colorectal cancer

New molecule promotes gut healing and suppresses tumor growth in colorectal cancer

New atlas maps 1.6 million human gut cells in unprecedented detail

New atlas maps 1.6 million human gut cells in unprecedented detail

Electrical stimulation of vagus nerve could combat inflammatory bowel disease

Electrical stimulation of vagus nerve could combat inflammatory bowel disease

Landmark study highlights growing pediatric IBD rates across the U.S.

Landmark study highlights growing pediatric IBD rates across the U.S.

Microbial density in our gut shapes how diseases are linked to gut health

Microbial density in our gut shapes how diseases are linked to gut health

Link between COVID-19 and long-term risk of autoimmune and autoinflammatory connective tissue disorders

Link between COVID-19 and long-term risk of autoimmune and autoinflammatory connective tissue disorders

New biomarker could predict response to IBD treatment

New biomarker could predict response to IBD treatment

Binghamton University joins groundbreaking $42.8 million inflammatory disease treatment project

Binghamton University joins groundbreaking $42.8 million inflammatory disease treatment project

Link between inflammatory bowel disease and spondyloarthritis revealed

Link between inflammatory bowel disease and spondyloarthritis revealed

Helene and CVS land double whammy for 25,000 patients who survive on IV nutrition

Helene and CVS land double whammy for 25,000 patients who survive on IV nutrition

Early signs of inflammatory bowel disease detected in newborns

Early signs of inflammatory bowel disease detected in newborns

Scientists uncover two Crohn’s disease subtypes using lab-grown intestines, offering hope for personalized therapies

Scientists uncover two Crohn’s disease subtypes using lab-grown intestines, offering hope for personalized therapies

Patient-derived gut organoids reveal new insights into Crohn's disease subtypes

Patient-derived gut organoids reveal new insights into Crohn's disease subtypes

Targeted drug therapy shows promise for ulcerative colitis remission

Targeted drug therapy shows promise for ulcerative colitis remission

Researchers gain new understanding of how immune cells respond to heat during fever

Researchers gain new understanding of how immune cells respond to heat during fever

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.